2021
DOI: 10.1016/j.jtct.2021.01.010
|View full text |Cite
|
Sign up to set email alerts
|

Serotherapy-Free Regimen Improves Non-Relapse Mortality and Immune Recovery Among the Recipients of αβ TCell–Depleted Haploidentical Grafts: Retrospective Study in Childhood Leukemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(18 citation statements)
references
References 25 publications
0
4
0
Order By: Relevance
“…All three are widely adopted when treating leukemia and autoimmune diseases, but because the toxicity of 6-TG is higher compared to of 6-MP and AZA, 6-TG is generally only adopted in patients with failed or intolerant treatment of 6-MP and AZA. Thiopurine drugs are prodrugs, and their metabolism in vivo is a complex process [ 5 ]. AZA can be rapidly converted to 6-mercaptopurine under the action of glutathione S-transferase.…”
Section: Introductionmentioning
confidence: 99%
“…All three are widely adopted when treating leukemia and autoimmune diseases, but because the toxicity of 6-TG is higher compared to of 6-MP and AZA, 6-TG is generally only adopted in patients with failed or intolerant treatment of 6-MP and AZA. Thiopurine drugs are prodrugs, and their metabolism in vivo is a complex process [ 5 ]. AZA can be rapidly converted to 6-mercaptopurine under the action of glutathione S-transferase.…”
Section: Introductionmentioning
confidence: 99%
“…The incidence of CMV reactivation was 45-50% in the experimental mDLI arm and 54-55% in the control arm. The median duration of CMV viremia was 3 weeks (range, 1-9) in the prospective cohort and 4 weeks (range, 1-26) in the historical cohort (105). Memory DLI was associated with improved CMVspecific T-cell reconstitution in a subcohort of CMV IgG seropositive recipients.…”
Section: Prophylactic DLImentioning
confidence: 87%
“…Prophylactic and therapeutic DLI are administered to improve posttransplant immune restoration to reduce both infectious complications and disease relapse. Michael Maschan et al investigated low-dose memory (CD45RA-depleted) donor lymphocyte infusion (mDLI) after ab T-cell depleted HSCT (103)(104)(105). The incidence of CMV reactivation was 45-50% in the experimental mDLI arm and 54-55% in the control arm.…”
Section: Prophylactic DLImentioning
confidence: 99%
See 1 more Smart Citation
“…Одним із факторів, що впливають на термін експлуатації інструменту гарячого деформування, є температура [12][13][14][15][16][17], зокрема її вплив на процеси в поверхневому та підповерхневому шарах [18][19][20][21][22][23][24][25]:…”
Section: аналіз публікаційunclassified